Conditions: Erectile Dysfunction
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 618
Healthy volunteers: no

Brief summary:
Randomized, placebo-controlled, double-blind, parallel design, Phase 3 study to evaluate the safety and efficacy of udenafil, an orally administered, potent and selective inhibitor of PDE-5 versus placebo for the treatment of subjects with erectile dysfunction (ED).

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None arm 4: None

Interventions: intervention 1: Udenafil intervention 2: Placebo
Intervention descriptions: intervention 1: Tablets via oral administration before an attempt at sexual intercourse. intervention 2: Tablets via oral administration before an attempt at sexual intercourse.

Protocol document: